インドの医薬品物流市場：タイプ別、手順別、コンポーネント別、用途別、運用別、地域別、機会、予測、2019年～2033年

インドの医薬品物流の市場規模は、8.12％のCAGRで拡大し、2025年の39億3,000万米ドルから2033年には73億4,000万米ドルに成長すると予測されています。インドの物流企業は、冷凍トラック、GPSモニター付きコンテナ、データロガー、製薬メーカーとの提携などへの投資を通じて適応しています。インドの医薬品物流市場は、単に進化しているだけでなく、コンプライアンス、コールドチェーンの拡大、ラストワンマイルの完全性を中心に再調整されています。インドは世界最大のジェネリック医薬品の供給国であり、ワクチンの重要な供給国でもあるため、医薬品グレードのロジスティクスへの期待はかつてないほど高まっています。従来の倉庫から流通までのモデルは、特にバイオ医薬品や特殊医薬品の需要が高まる中、温度監視、デジタル追跡、リアルタイムの可視化によって多層的なエコシステムへと進化しています。

さらに、医薬品サプライチェーンはより患者中心になってきています。電子薬局、温度の影響を受けやすい原薬、個別化医療の増加により、新たな複雑なレイヤーが導入され、高いサービスレベル、迅速なフルフィルメント、厳格な取り扱いプロトコルが求められています。PM Gati ShaktiプログラムやCDSCO（中央医薬品標準管理機関）のガイドライン改訂といった政府の取り組みにより、多段階輸送の接続性が改善され、保管・輸送条件の調和が図られています。さらに、インドの医薬品市場は非常に成長しています。例えば、国連人口基金（UNFPA）の推計によると、インドでは2050年までに約3億4,700万人が60歳以上になると予想されています。高齢者は病気にかかりやすくなるため、医薬品への需要がさらに高まり、インドの医薬品物流市場を牽引すると予想されます。

当レポートでは、インドの医薬品物流市場について調査し、市場の概要とともに、タイプ別、手順別、コンポーネント別、用途別、運用別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 米国の関税の影響

第4章 エグゼクティブサマリー

第5章 お客様の声

第6章 インドの医薬品物流市場の見通し、2019年～2033年

• 市場規模分析と予測
• 市場シェア分析と予測
  • タイプ別
    • コールドチェーン物流
    • 非コールドチェーン物流
  • 手順別
    • ピッキング
    • ストレージ
    • 検索システム
    • ハンドリングシステム
  • コンポーネント別
    • 保管
    • 輸送
    • コンポーネントのモニタリング
  • 用途別
    • 化学薬品
    • バイオ医薬品
    • 専門医薬品
  • 運用別
    • 海路
    • 道路
    • 鉄道
    • 航空
    • ストレージとサービス
  • 地域別
    • 北部
    • 東部
    • 西部と中央部
    • 南部
  • 企業別市場シェア分析（上位5社およびその他- 金額ベース、2025年）
• 2025年の市場マップ分析

第7章 需要供給分析

第8章 バリューチェーン分析

第9章 ポーターのファイブフォース分析

第10章 PESTLE分析

第11章 サービス価格分析

第12章 市場力学

• 市場の促進要因
• 市場の課題

第13章 消費者購買行動分析

第14章 市場動向と発展

第15章 政策と規制状況

第16章 ケーススタディ

第17章 競合情勢

• 市場リーダートップ5の競合マトリックス
• 参入企業トップ5のSWOT分析
• 市場の主要企業トップ10の情勢
  • Allcargo Logistics Ltd.
  • Safexpress Pvt. Ltd.
  • Mahindra Logistics Limited
  • AWL India Private Limited
  • Snowman Logistics Pvt Ltd
  • EasyWay Logistics Pvt Ltd
  • Stellar Value Chain Solutions Pvt Ltd
  • Future Supply Chain Solutions Ltd.
  • Varuna Group
  • TCI Express Ltd.

第18章 戦略的提言

第19章 調査会社について・免責事項

List of Tables

• Table 1. Competition Matrix of Top 5 Market Leaders
• Table 2. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 3. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. India Pharmaceutical Logistics Market, By Value, In USD Billion, FY2019-FY2033F
• Figure 2. India Pharmaceutical Logistics Market Share (%), By Type, FY2019-FY2033F
• Figure 3. India Pharmaceutical Logistics Market Share (%), By Procedure, FY2019-FY2033F
• Figure 4. India Pharmaceutical Logistics Market Share (%), By Component, FY2019-FY2033F
• Figure 5. India Pharmaceutical Logistics Market Share (%), By Application, FY2019-FY2033F
• Figure 6. India Pharmaceutical Logistics Market Share (%), By Operation, FY2019-FY2033F
• Figure 7. India Pharmaceutical Logistics Market Share (%), By Region, FY2019-FY2033F
• Figure 8. By Type Map-Market Size (USD Billion) & Growth Rate (%), FY2025
• Figure 9. By Procedure Map-Market Size (USD Billion) & Growth Rate (%), FY2025
• Figure 10. By Component Map-Market Size (USD Billion) & Growth Rate (%), FY2025
• Figure 11. By Application Map-Market Size (USD Billion) & Growth Rate (%), FY2025
• Figure 12. By Operation Map-Market Size (USD Billion) & Growth Rate (%), FY2025
• Figure 13. By Region Map-Market Size (USD Billion) & Growth Rate (%), FY2025

Indian pharmaceutical logistics market is projected to witness a CAGR of 8.12% during the forecast period, FY2026-FY2033, growing from USD 3.93 billion in FY2025 to USD 7.34 billion in FY2033, driven by surging exports, rising domestic consumption, and increased regulatory scrutiny. India's logistics players are adapting through investments in reefer trucks, GPS-monitored containers, data loggers, and partnerships with pharmaceutical manufacturers. India's pharmaceutical logistics market is not just evolving, it is recalibrating around compliance, cold chain expansion, and last-mile integrity. With India being the world's largest provider of generic medicines and a critical supplier of vaccines, the stakes for pharma-grade logistics have never been higher. The traditional warehousing-to-distribution model has evolved into a multi-tiered ecosystem driven by temperature monitoring, digital tracking, and real-time visibility, particularly with the rising demand for biopharma and specialty drugs.

Moreover, the pharma supply chain is becoming more patient-centric. The growth of e-pharmacies, temperature-sensitive APIs, and personalized medicine has introduced a new complexity layer, demanding high service levels, rapid fulfillment, and strict handling protocols. Government initiatives such as the PM Gati Shakti programme and revised guidelines under CDSCO (Central Drugs Standard Control Organization) are improving multimodal connectivity and harmonizing storage and transit conditions. Additionally, the Indian pharmaceutical market is growing enormously. For instance, as per the estimates of the United Nations Population Fund (UNFPA), approximately 347 million individuals in India are expected to be sixty or older by 2050. This is further expected to boost the requirement for pharmaceuticals as the elderly are more susceptible to diseases, driving the India pharmaceutical logistics market.

Market Growth due to Surge in Cold Chain Demand Due to Biopharma and Specialty Drugs

Cold chain logistics is no longer a niche in India; it is becoming the standard for high-value pharmaceutical movement. Biologics, vaccines, insulin, and advanced therapies require a tightly controlled cold chain infrastructure, from production to the patient.

In September 2023, India's Ministry of Health & Family Welfare issued new draft norms requiring mandatory validation of cold storage facilities for vaccine and insulin supply chains, both for public and private sector logistics players. This has led to a significant private sector response. In January 2024, Snowman Logistics inaugurated a new pharma-grade cold storage facility in the Northeast in January 2024, adding around 5,000 pallets of 2-8°C storage, specifically catering to vaccine and biologics clients in western India.

The rising demand from clinical trials and the growing portfolio of India's biopharma exports, including mRNA and biosimilars, are also pushing 3PLs to upgrade infrastructure. Gati Kausar and ColdEx have both announced fleet expansion plans for pharma-grade reefer trucks with continuous temperature monitoring. Cold chain is no longer an optional add-on; it is a competitive mandate.

Multimodal Logistics Expansion and Policy Support Leading to an Increase in Market Reach

Logistics players are finally moving beyond just roads. India's multimodal push, especially under PM Gati Shakti, is reconfiguring pharma logistics routes for better time-cost efficiency. Rail and air freight are gaining traction for high-value, low-volume drugs that need speed and precision.

In February 2024, the Indian Railways launched Pharma Express, a dedicated temperature-controlled freight service between Hyderabad and Delhi, with pre-booked reefer containers and validated SOPs in partnership with logistics players such as TCI Express Limited and Allcargo Logistics Limited.

Meanwhile, air cargo terminals in Delhi, Mumbai, and Hyderabad have seen capacity upgrades, including pharma corridors with end-to-end cold chain monitoring, coordinated by the Air Cargo Forum India (ACFI) and AAI Cargo Logistics & Allied Services (AAICLAS).

The growing export of bulk drugs, APIs, and high-value generics, particularly to the U.S. and Europe, is making multimodal logistics not just viable but essential. Add to this, policy-level clarity around standardization, and logistics firms now have an environment conducive to infrastructure scaling.

Dominance of Biopharma Application in Logistics Spend

Among all pharmaceutical verticals, biopharma commands the highest logistics complexity and spend, making it the dominant segment in India's pharmaceutical logistics landscape. Biopharmaceuticals have stringent temperature requirements (2-8 degrees Celsius or even 20 degrees Celsius for some mAbs), short shelf lives, and often involve bulk movement to centralized cold chain hubs for global distribution. With India emerging as a preferred CDMO (Contract Development and Manufacturing Organization) partner for global biologics, logistics has taken center stage.

In July 2023, Biocon Biologics expanded its export footprint by shipping biosimilars from its Bengaluru site to 70 countries, supported by partnerships with Stellar Value Chain Solutions for packaging, conditioning, and validated route mapping.

Biopharma also includes temperature-sensitive clinical trial logistics - an area that has grown as India becomes a testbed for global Phase II/III studies. Logistics providers catering to this segment are adding passive containers, validated SOPs, and a GDP-trained workforce to maintain regulatory compliance. This sub-sector's precision demands are setting new industry benchmarks and commanding premium pricing in logistics contracts.

Impact of U.S. Tariffs on India Pharmaceutical Logistics Market

U.S. tariffs on pharmaceuticals on Indian goods and pharma products will disrupt India's pharmaceutical exports, and the pharma supply chain will largely impact "exports" & "cost to the supply chain." Specifically, the U.S. can impose higher tariffs on drugs or APIs manufactured in India. Increased pharmaceutical logistics providers may face the following issues: Reduced export, increased warehousing diversification in other markets such as Africa, Europe, and Latin America, exponentially high input costs: Raw materials are expensive or increase prices, e.g., tariffs on "Chinese intermediates used in Indian pharma." Increases warehousing and transportation costs, such as the cold chain, which is more expensive.

Key Players Landscape and Outlook

India's pharmaceutical logistics market is relatively fragmented, but clear leaders are emerging based on service specialization, cold chain depth, and multimodal adaptability. Snowman Logistics, Gati Kausar, and ColdEx lead the cold chain space with pharma-grade warehouses and reefer fleets. Stellar Value Chain and TCI Express are strong in multi-zone transport and compliance-driven packaging solutions. Many players are integrating real-time visibility platforms, investing in blockchain-based tracking, and training the workforce under WHO-GDP guidelines. Mahindra Logistics Limited and Reefer Express, though smaller, have carved out niches in intra-state biopharma supply. What differentiates players now is not just delivery timelines, but how well they can comply, monitor, and adapt in an increasingly regulated and digitized ecosystem.

In December 2023, the boards of Allcargo Logistics Limited and Allcargo Gati Limited approved a composite scheme of arrangement to restructure their businesses. Under the plan, the International Supply Chain (ISC) business-including both the India operations and international subsidiaries-demerged into a new entity, Allcargo ECU Limited. The remaining express and contract logistics businesses were consolidated under Allcargo Logistics. This restructuring aimed to simplify the corporate structure, enhance synergies, and provide direct shareholding to Allcargo and Allcargo Gati shareholders.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Impact of U.S. Tariffs

4. Executive Summary

5. Voice of Customers

• 5.1. Regulatory Compliance
• 5.2. Quality Management and Traceability
• 5.3. Industry Experience and Reputation
• 5.4. Customer Service and Support

6. India Pharmaceutical Logistics Market Outlook, FY2019-FY2033F

• 6.1. Market Size Analysis & Forecast
  • 6.1.1. By Value
• 6.2. Market Share Analysis & Forecast
  • 6.2.1. By Type
    • 6.2.1.1. Cold Chain Logistics
    • 6.2.1.2. Non-Cold Chain Logistics
  • 6.2.2. By Procedure
    • 6.2.2.1. Picking
    • 6.2.2.2. Storage
    • 6.2.2.3. Retrieval Systems
    • 6.2.2.4. Handling Systems
  • 6.2.3. By Component
    • 6.2.3.1. Storage
    • 6.2.3.2. Transportation
    • 6.2.3.3. Monitoring Components
  • 6.2.4. By Application
    • 6.2.4.1. Chemical Pharma
    • 6.2.4.2. Biopharma
    • 6.2.4.3. Specialized Pharma
  • 6.2.5. By Operation
    • 6.2.5.1. Seaways
    • 6.2.5.2. Roadways
    • 6.2.5.3. Railways
    • 6.2.5.4. Airways
    • 6.2.5.5. Storage and Services
  • 6.2.6. By Region
    • 6.2.6.1. North
    • 6.2.6.2. East
    • 6.2.6.3. West and Central
    • 6.2.6.4. South
  • 6.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, FY2025)
• 6.3. Market Map Analysis, FY2025
  • 6.3.1. By Type
  • 6.3.2. By Procedure
  • 6.3.3. By Component
  • 6.3.4. By Application
  • 6.3.5. By Operation
  • 6.3.6. By Region

7. Demand Supply Analysis

8. Value Chain Analysis

9. Porter's Five Forces Analysis

10. PESTLE Analysis

11. Service Pricing Analysis

12. Market Dynamics

• 12.1. Market Drivers
• 12.2. Market Challenges

13. Consumer Buying Behavior Analysis

14. Market Trends and Developments

15. Policy and Regulatory Landscape

16. Case Studies

17. Competitive Landscape

• 17.1. Competition Matrix of Top 5 Market Leaders
• 17.2. SWOT Analysis for Top 5 Players
• 17.3. Key Players Landscape for Top 10 Market Players
  • 17.3.1. Allcargo Logistics Ltd.
    • 17.3.1.1. Company Details
    • 17.3.1.2. Key Management Personnel
    • 17.3.1.3. Products and Services
    • 17.3.1.4. Financials (As Reported)
    • 17.3.1.5. Key Market Focus and Geographical Presence
    • 17.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisition
  • 17.3.2. Safexpress Pvt. Ltd.
  • 17.3.3. Mahindra Logistics Limited
  • 17.3.4. AWL India Private Limited
  • 17.3.5. Snowman Logistics Pvt Ltd
  • 17.3.6. EasyWay Logistics Pvt Ltd
  • 17.3.7. Stellar Value Chain Solutions Pvt Ltd
  • 17.3.8. Future Supply Chain Solutions Ltd.
  • 17.3.9. Varuna Group
  • 17.3.10. TCI Express Ltd.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

18. Strategic Recommendations

19. About Us and Disclaimer